CAPPELLARI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.616
EU - Europa 212
AS - Asia 137
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.615
IT - Italia 119
CN - Cina 90
VN - Vietnam 38
SE - Svezia 28
FI - Finlandia 22
DE - Germania 12
GB - Regno Unito 11
IN - India 7
IE - Irlanda 5
UA - Ucraina 5
FR - Francia 3
ES - Italia 2
CA - Canada 1
CH - Svizzera 1
EU - Europa 1
IQ - Iraq 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.967
Salva come PNG Salva come JPEG
Città #
Fairfield 315
Chandler 198
Woodbridge 159
Ashburn 121
Houston 120
Cambridge 106
Seattle 102
Ann Arbor 101
Wilmington 71
Padova 39
Dong Ket 38
San Diego 28
Des Moines 27
Medford 23
Princeton 23
Beijing 17
Dearborn 15
New York 15
Helsinki 13
Roxbury 13
Boardman 11
Guangzhou 11
Milan 8
Nanjing 8
Jinan 7
Cagliari 6
Shanghai 6
Dublin 5
Hebei 4
London 4
Shenyang 4
Bari 3
Los Angeles 3
Munich 3
Nanchang 3
Ningbo 3
Ogden 3
Rome 3
Selvazzano Dentro 3
Zhengzhou 3
Bologna 2
Chieti 2
Cosenza 2
Hangzhou 2
Hefei 2
Jiaxing 2
Kharkiv 2
Kunming 2
Monza 2
Orange 2
Paris 2
Parma 2
Ponsacco 2
Pune 2
Redwood City 2
Rimini 2
Rockville 2
Siano 2
Tianjin 2
Borås 1
Chicago 1
Ciudad-rodrigo 1
Deiva Marina 1
Frankfurt am Main 1
Fuzhou 1
Geneva 1
Gragnano 1
Indiana 1
Kasugai 1
Lappeenranta 1
Legnaro 1
Little Rock 1
Mcallen 1
Monmouth Junction 1
Nitra 1
Pinehaven 1
Portland 1
Redmond 1
Rovereto 1
San Mateo 1
Scafati 1
Shannonville 1
Sommacampagna 1
Stockholm 1
Taizhou 1
Timisoara 1
Torino 1
Treviso 1
Vicenza 1
Wuhan 1
Xian 1
Zhytomyr 1
Ürümqi 1
Totale 1.717
Salva come PNG Salva come JPEG
Nome #
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 168
NETosis delays diabetic wound healing in mice and humans 168
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 155
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 154
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 120
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 109
The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk 103
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 97
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects 84
Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry 81
Shift of monocyte subsets along their continuum predicts cardiovascular outcomes 76
Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis 72
Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes 71
Effects of SGLT2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes 70
The monocyte continuum and cardiovascular disease: Evaluation of the prognostic cardiovascular meaning of monocyte displacement along their continuum 69
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes 59
Diabetes mellitus impairs circulating proangiogenic granulocytes 54
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial 54
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 51
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes 49
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 45
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 33
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 17
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study 17
Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome 13
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults 12
Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features 5
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells 2
Circulating haematopoietic stem cells and long-term outcomes of COVID-19 1
Totale 2.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.105
article - articoli 7.806
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019111 0 0 0 0 0 0 0 0 0 0 57 54
2019/2020415 35 19 5 27 41 43 63 43 46 26 42 25
2020/2021490 13 32 48 31 6 21 16 37 34 139 49 64
2021/2022315 7 18 28 31 32 24 13 33 23 8 16 82
2022/2023340 59 48 5 47 51 47 8 22 34 3 13 3
2023/2024179 5 23 33 21 8 26 15 13 10 20 5 0
Totale 2.009